NYSEARCA:JJS iPath Series B Bloomberg Softs Subindex Total Return ETN (JJS) Price, Holdings, & News → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free JJS Stock Alerts $71.99 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$71.99▼$71.9950-Day Range$71.99▼$71.9952-Week Range$54.14▼$74.52VolumeN/AAverage Volume2,247 shsMarket Capitalization$7.20 millionAssets Under Management$367,200.00Dividend Yield0.00%Net Expense Ratio0.45% Stock AnalysisStock AnalysisChartStock AnalysisChart Get iPath Series B Bloomberg Softs Subindex Total Return ETN alerts: Email Address About iPath Series B Bloomberg Softs Subindex Total Return ETN (NYSEARCA:JJS)Read More JJS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JJS ETF News HeadlinesFebruary 28, 2023 | finance.yahoo.comCapgemini Expands Its 5G Innovation Program With New ‘5G Solutions Center’ in San FranciscoFebruary 27, 2023 | finance.yahoo.comSchneider Electric and Capgemini collaborate to accelerate 5G industrial automation, supported by QualcommApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 10, 2023 | finance.yahoo.comiPath Series B Bloomberg Softs Subindex Total Return ETN (JJS)January 26, 2023 | finance.yahoo.com80% of public sector organizations have started implementing data sharing initiatives according to a new report from the Capgemini Research InstituteJanuary 26, 2023 | finance.yahoo.comOil Edges Higher as China Demand and US Dollar Take Center StageJanuary 16, 2023 | finance.yahoo.comWhere are organizations investing in 2023? Supply chains and tech are top of the listJanuary 10, 2023 | finance.yahoo.comCapgemini reinforces its focus on global industries and sustainability services with top leadership appointmentsApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.January 9, 2023 | finance.yahoo.comEnabling cost reductions will be key for retailers to attract today’s frugal consumerSee More Headlines Receive JJS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iPath Series B Bloomberg Softs Subindex Total Return ETN and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerBarclays Capital Fund NameiPath Series B Bloomberg Softs Subindex Total Return ETN Tax ClassificationExchange-Traded Note Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:JJS Inception Date1/17/2018 Fund ManagerN/A Webwww.barclays.co.uk Phone442071161000Fund Focus Asset ClassCommodities BenchmarkBloomberg Softs Subindex Total Return CategoryAgriculture FocusSofts Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$367,200.00 Average Daily Volume$359.10 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares100,000BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> iPath Series B Bloomberg Softs Subindex Total Return ETN ExpensesTypeJJSSofts ETFsCommodities ETFsNYSEARCA ETFsAll ETFsManagement Fee0.00%0.00%0.66%0.50%0.51%Other Expenses0.00%0.00%0.27%0.64%0.58%Total Expense0.00%0.00%0.77%0.74%0.70%Fee Waiver0.00%0.00%-0.18%-0.68%-0.57%Net Expense0.45%0.45%0.70%0.58%0.58% iPath Series B Bloomberg Softs Subindex Total Return ETN (JJS)Full Holdings Details Similar ETFsiPath B Bloomberg Softs Ttl Ret ETNNYSEARCA:JJSB JJS ETF - Frequently Asked Questions How have JJS shares performed in 2024? iPath Series B Bloomberg Softs Subindex Total Return ETN's stock was trading at $71.99 at the start of the year. Since then, JJS stock has increased by 0.0% and is now trading at $71.99. View the best growth stocks for 2024 here. What does JJS invest in? iPath Series B Bloomberg Softs Subindex Total Return ETN is a commodities fund issued by Barclays Capital. JJS focuses on softs investments and follows the Bloomberg Softs Subindex Total Return. The fund's investments total to approximately $367,200.00 assets under management. How do I buy shares of iPath Series B Bloomberg Softs Subindex Total Return ETN? Shares of JJS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:JJS) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iPath Series B Bloomberg Softs Subindex Total Return ETN Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
